Medicine and Dentistry
Lower Urinary Tract Symptom
95%
Interstitial Cystitis
74%
Stress Incontinence
63%
Overactive Bladder
63%
Cystalgia
62%
Neobladder
59%
Metabolic Syndrome
59%
Cystectomy
52%
Pain
50%
International Prostate Symptom Score
50%
Nocturia
49%
Prospective Study
47%
Biofeedback
47%
Functional Electrical Stimulation
47%
Vulvodynia
46%
Kegel Exercise
42%
Sensation
41%
Voiding Dysfunction
35%
Tamsulosin
35%
Afferent Nerve Fiber
35%
Sacral Nerve Stimulation
35%
Sex Difference
30%
Prostate Cancer
30%
Disease
29%
Micturition
29%
Botulinum Toxin A
23%
Percutaneous Nephrolithotomy
23%
Epithelial Cell
23%
Transitional Cell Carcinoma
23%
Elderly Population
23%
Retrospective Cohort Study
23%
Chronic Pelvic Pain Syndrome
23%
Visual Stimulation
23%
Bowel Obstruction
23%
Somatic Mutation
23%
K-Complex
23%
2 Oxoglutaric Acid
23%
Cell-Free DNA
23%
Peripheral Nervous System
23%
Receptor Binding
23%
Endocrine System
23%
Treatment Response
23%
Vascular System
23%
Gene Therapy
23%
Metastatic Carcinoma
23%
Robot-Assisted Prostatectomy
23%
Growth Factor
23%
Pulse Generator
23%
Urodynamics
22%
Paralytic Ileus
21%
Pharmacology, Toxicology and Pharmaceutical Science
Overactive Bladder
100%
Lower Urinary Tract Symptom
71%
Prostate Hypertrophy
50%
Metabolic Syndrome X
47%
2 Oxoglutaric Acid
47%
Vulvodynia
47%
Botulinum Toxin A
43%
Bladder Cancer
39%
Sprague Dawley Rat
37%
Interstitial Cystitis
35%
Nitric Oxide Synthase
35%
Western Blot
34%
Rho Kinase
29%
Endothelial Nitric Oxide Synthase
26%
Retrospective Study
26%
Pelvis Pain Syndrome
26%
Adverse Event
26%
Urine Incontinence
26%
Enuresis
26%
Placebo
24%
Syndrome
23%
Prostate Cancer
23%
Metastasis
23%
Intestine Obstruction
23%
Cranberry
23%
Cohort Study
23%
Phosphotransferase
23%
Collagen Type 1
23%
Neuronal Nitric Oxide Synthase
23%
Neurotransmitter
23%
Sex Hormone
23%
Fesoterodine
23%
Prospective Study
23%
Tamsulosin
23%
Cholinergic Receptor Blocking Agent
23%
Clinical Study
23%
Obstruction
23%
Cystalgia
23%
Urinary Tract Infection
21%
Paralytic Ileus
21%
Gabapentin
19%
Infection
16%
Collagen Type 3
15%
Stress Incontinence
15%
Monotherapy
14%
Pathophysiology
13%
Prostate Specific Antigen
12%
Pain
11%
Bladder Dysfunction
11%
Intracavernous Injection
11%
Nursing and Health Professions
Overactive Bladder
59%
Enuresis
39%
Urine Incontinence
39%
Quality of Life
36%
Lower Urinary Tract Symptom
28%
Interstitial Cystitis
26%
Stress Incontinence
26%
2 Oxoglutaric Acid
23%
Syndrome
23%
Prostate Hypertrophy
23%
Sacral Nerve Stimulation
23%
Visual Stimulation
23%
Phosphotransferase
23%
Nitric Oxide Synthase
23%
Pulse Generator
23%
Perceptive Threshold
23%
Functional Electrical Stimulation
23%
Pelvic Floor Muscle Training
23%
Kidney Stone
23%
Biofeedback
23%
Bladder Obstruction
11%
Factor Analysis
11%
International Prostate Symptom Score
11%
Monotherapy
11%
Prostate Volume
11%
Diagnostic Value
11%
Alpha Adrenergic Receptor Blocking Agent
11%
Measurement
11%
Psychogenic Pain
11%
Libido Disorder
11%
Urinalysis
11%
Neurologic Disease
11%
Disease
11%
Incontinence
11%
Functional Magnetic Resonance Imaging
10%
Social Life
8%
Surgery
7%
Physician
5%
Vulvodynia
5%
Rho Kinase
5%
Pathophysiology
5%
Urge Incontinence
5%
Female Patient
5%
Operation Duration
5%
Perineometer
5%
Conservative Treatment
5%
